Publications by authors named "Iris Gersten"

Claim this Profile
E
Easy-to-Read Informed Consent Form for Hematopoietic Cell Transplantation Clinical Trials: Results from the Blood and Marrow Transplant Clinical Trials Network 1205 Study.
Ryan Spellecy, Sergey Tarima, Ellen Denzen, Heather Moore, Sunil Abhyankar, Iris Gersten

Biol Blood Marrow Transplant· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A trial of unrelated donor marrow transplantation for children with severe sickle cell disease.
Shalini Shenoy, Mary Eapen, Julie A Panepinto, Brent R Logan, Juan Wu, Iris Gersten

Blood· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and High-Dose Rituximab for Allogeneic Hematopoietic Cell Transplantation for Follicular Lymphoma: A Phase Two Multicenter Trial from the Blood and Marrow Transplant Clinical Trials Network.
Ginna G Laport, Juan Wu, Brent Logan, Veronika Bachanova, Chitra Hosing, Iris Gersten

Biol Blood Marrow Transplant· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclophosphamide conditioning in patients with severe aplastic anaemia given unrelated marrow transplantation: a phase 1-2 dose de-escalation study.
Paolo Anderlini, Juan Wu, Iris Gersten, Marian Ewell, Jakob Tolar

Lancet Haematol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative cost-effectiveness analysis of voriconazole and fluconazole for prevention of invasive fungal infection in patients receiving allogeneic hematopoietic cell transplants.
Josephine Mauskopf, Costel Chirila, Jon Graham, Iris D Gersten, Helen Leather

Am J Health Syst Pharm· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fludarabine-based conditioning for marrow transplantation from unrelated donors in severe aplastic anemia: early results of a cyclophosphamide dose deescalation study show life-threatening adverse events at predefined cyclophosphamide dose levels.
Jakub Tolar, H Joachim Deeg, Sally Arai, Mitchell Horwitz, Joseph H Antin, Iris D Gersten

Biol Blood Marrow Transplant· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Easy-to-read informed consent forms for hematopoietic cell transplantation clinical trials.
Ellen M Denzen, Martha E Burton Santibáñez, Heather Moore, Amy Foley, Iris D Gersten

Biol Blood Marrow Transplant· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation.
John R Wingard, Shelly L Carter, Thomas J Walsh, Joanne Kurtzberg, Trudy N Small, Iris D Gersten

Blood· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis